PUBLISHER: The Business Research Company | PRODUCT CODE: 1945565
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945565
Medical low-value consumables are inexpensive, single-use products frequently used in healthcare environments, including gloves, bandages, syringes, and masks. These disposable items are vital for everyday medical procedures but do not significantly contribute to the revenue of healthcare systems due to their low cost.
The primary types of medical low-value consumables include syringes, needles, gloves, bandages, and catheters. Syringes are crucial medical instruments for injecting or withdrawing fluids from the body. They are made from various materials such as plastic, glass, metal, biodegradable substances, and synthetic polymers. These consumables are categorized by usage types, including single-use, reusable, disposable, and repairable products. They are utilized by a broad range of end-users, including hospitals, clinics, diagnostic labs, home care settings, and research laboratories.
Tariffs have increased the cost of imported plastics, synthetic polymers, rubber, and metal components used in medical low value consumables, raising overall product prices. These impacts are most pronounced in gloves, syringes, and catheters, particularly in Asia-Pacific and Europe where raw material sourcing is highly globalized. Higher costs have affected procurement budgets for hospitals and clinics. However, tariffs have also encouraged local manufacturing and sourcing of consumables, strengthening domestic supply chains and improving long term supply security.
The medical low value consumables market research report is one of a series of new reports from The Business Research Company that provides medical low value consumables market statistics, including medical low value consumables industry global market size, regional shares, competitors with a medical low value consumables market share, detailed medical low value consumables market segments, market trends and opportunities, and any further data you may need to thrive in the medical low value consumables industry. This medical low value consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical low value consumables market size has grown strongly in recent years. It will grow from $13.15 billion in 2025 to $13.91 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to routine medical procedures growth, hospital patient volume increase, infection prevention protocols, expansion of diagnostic services, availability of low-cost disposables.
The medical low value consumables market size is expected to see strong growth in the next few years. It will grow to $17.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growth of home care services, emphasis on hygiene compliance, expansion of healthcare access, demand for biodegradable consumables, supply chain localization. Major trends in the forecast period include rising demand for disposable medical products, increased focus on infection control, growth of high-volume hospital procurement, shift toward cost-optimized consumables, expansion of home healthcare usage.
The rising prevalence of chronic diseases is expected to propel the growth of the medical low-value consumables market going forward. Chronic diseases are long-lasting conditions that typically progress slowly, such as diabetes, cardiovascular diseases, and cancer. The increasing burden of chronic diseases is driven by factors such as aging populations, lifestyle changes, unhealthy diets, physical inactivity, and prolonged exposure to environmental risk factors. Medical low-value consumables-including gloves, syringes, tubing, dressings, and basic diagnostic disposables-play a crucial role in the routine monitoring, diagnosis, and ongoing management of chronic conditions by supporting frequent clinical visits, laboratory testing, and treatment administration. For instance, in June 2023, according to Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK were living with chronic kidney disease, representing over 10% of the population, with 3.25 million in advanced stages and 3.9 million in early stages. The number of affected individuals is projected to increase to 7.61 million by 2033. Therefore, the rising prevalence of chronic diseases is driving the growth of the medical low-value consumables market.
Major companies operating in the medical low-value consumables market are focusing on launching silicone-oil-free prefillable syringe systems, such as silicone-oil-free ready-to-fill (RTF) glass and COP (cyclic olefin polymer) syringes, to improve drug safety, regulatory compliance, and compatibility with sensitive formulations. These single-use, pre-sterilized drug-delivery containers eliminate silicone-oil particle contamination, reducing the risk of protein aggregation and particulate formation that can compromise biologics and advanced therapies. By enhancing drug purity, dose accuracy, and patient safety, such innovations are becoming increasingly important as biologics and specialty injectables gain wider adoption. For instance, in April 2025, Gerresheimer, a Germany-based pharmaceutical systems company, launched a new generation of silicone-oil-free and PFAS-free prefillable syringe systems manufactured in both glass and COP. The syringes feature a completely silicone-oil-free barrel to significantly reduce particulate contamination and improve compatibility with sensitive biologics. In addition, PFAS-free plunger stoppers-developed through a licensing agreement with Injecto-support evolving regulatory and sustainability requirements. The platform also enables highly precise low-volume dosing, making it particularly suitable for ophthalmic applications and high-value biologic drugs where dosing accuracy and product integrity are critical.
In July 2024, Owens & Minor Inc., a US-based healthcare company, acquired Rotech Healthcare Holdings Inc. for $1.32 billion. This acquisition allows Owens & Minor to strengthen its position in the home respiratory and medical equipment market, enhancing its ability to provide end-to-end healthcare solutions. Rotech Healthcare Holdings Inc. is a US-based company offering medical low value consumables.
Major companies operating in the medical low value consumables market are Johnson & Johnson, 3M Company, Fresenius SE & Co., Becton Dickinson and Company (BD), Smith & Nephew plc, Nipro Corporation, Paul Hartmann AG, Ansell Limited, Halyard Health Inc., Blue Sail Medical Co. Ltd., B. Braun Melsungen AG, PW MedTech Group Limited, Allmed Medical Products Co. Ltd., Cardinal Health Inc., Medline Industries Inc., Dynarex Corporation, Molnlycke Health Care AB, Owens & Minor Inc., Sterimed Group, Narang Medical Limited, Romsons Group of Industries, Terumo Medical Corporation
North America was the largest region in the medical low-value consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical low value consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical low value consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical low-value consumables market consists of sales of personal protective equipment, surgical and wound care items, diagnostic and monitoring tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Low Value Consumables Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical low value consumables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical low value consumables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical low value consumables market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.